Pramirol 0.125 Tablet is a commercial drug that is prescribed in the form of Tablet. Parkinson's Disease are some of its major therapeutic uses. Other than this, Pramirol 0.125 Tablet has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Pramirol 0.125 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Pramirol 0.125 Tablet can also lead to other problems, which have been listed below. These side effects of Pramirol 0.125 Tablet are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Pramirol 0.125 Tablet's effect is Moderate during pregnancy and Severe for lactating mothers. In addition, Pramirol 0.125 Tablet's effects on the liver, heart and kidney are discussed below in the Pramirol 0.125 Tablet related warnings section.
Pramirol 0.125 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Pramirol 0.125 Tablet in conditions like Schizophrenia, Heart Disease, Kidney Disease.
Drug reaction of Pramirol 0.125 Tablet with other medicines has been reported. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Pramirol 0.125 Tablet is considered not safe while driving, and is not addictive.
Pramirol 0.125 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Pramirol 0.125 Tablet safe for pregnant women?
Pramirol can have harmful effects in pregnant women. If you experience any discomfort after using Pramirol, then discontinue the use and take your doctor's advice.
Is the use of Pramirol 0.125 Tablet safe during breastfeeding?
Taking Pramirol may lead to serious side effects if you are breastfeeding. Pramirol should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Pramirol 0.125 Tablet on the Kidneys?
Pramirol rarely harms the kidneys.
What is the effect of Pramirol 0.125 Tablet on the Liver?
Pramirol does not damage the liver.
What is the effect of Pramirol 0.125 Tablet on the Heart?
Very few cases of side effects of Pramirol on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Pramirol 0.125 Tablet unless your doctor advises you to do so -
Is this Pramirol 0.125 Tablet habit forming or addictive?
No, there is no any evidence that Pramirol 0.125 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Pramirol 0.125 Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Pramirol 0.125 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Yes, taking Pramirol 0.125 Tablet can treat mental disorders.
Interaction between Food and Pramirol 0.125 Tablet
Some foods when eaten with Pramirol 0.125 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Pramirol 0.125 Tablet
Taking Pramirol 0.125 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Mirapex® (pramipexole dihydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1043-1044
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 430-431
